Myocardial ischemia in patients with dilated cardiomyopathy

Dilated cardiomyopathy (DCM) is characterized by ventricular chamber enlargement and systolic dysfunction with normal ventricular wall thickness. More recent studies have shown that the coronary microcirculation may be directly affected in cardiomyopathies. Left ventricular regional myocardial perfusion, wall motion, and metabolism abnormalities are often present in patients with DCM. These data support the possibility that myocardial ischemia may play an important role in the development of DCM and have important prognostic value in patients with DCM. We need to pay attention to the assessment of myocardial blood flow and myocardial ischemia in patients with DCM. Furthermore, anti-ischemic therapy may improve left ventricular function and clinical outcomes in patients with heart failure resulted from DCM.

[1]  D. J. Veldhuisen,et al.  Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy , 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[2]  P. van der Harst,et al.  Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[3]  W. Fang,et al.  Evaluation of left ventricular volumes and ejection fraction by gated SPECT and cardiac MRI in patients with dilated cardiomyopathy , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  G. Breithardt,et al.  Myocardial Perfusion in Nonischemic Dilated Cardiomyopathy With and Without Atrial Fibrillation , 2009, Journal of Nuclear Medicine.

[5]  E. Agapitos,et al.  Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[6]  D. Jain,et al.  Direct imaging of myocardial ischemia: a potential new paradigm in nuclear cardiovascular imaging , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[7]  D. Neglia,et al.  Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study , 2008, Journal of cardiovascular medicine.

[8]  R. Testa,et al.  Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. , 2007, American journal of physiology. Heart and circulatory physiology.

[9]  P. Vardas,et al.  Acute effect of esmolol intravenously on coronary microcirculation in patients with idiopathic dilated cardiomyopathy. , 2007, The American journal of cardiology.

[10]  A. Gavazzi,et al.  Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy , 2007, Heart.

[11]  H. Gullu,et al.  Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy , 2006, Heart.

[12]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[13]  J. Higaki,et al.  Effect of Beta-Blocker Therapy on Myocardial Perfusion Defects in Thallium-201 Scintigraphy in Patients with Dilated Cardiomyopathy , 2005, Cardiology.

[14]  H. Demir,et al.  Assessment of left ventricular function and volumes for patients with dilated cardiomyopathy using gated myocardial perfusion SPECT and comparison with echocardiography , 2005, Nuclear medicine communications.

[15]  D. Neglia,et al.  Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy. , 2005, Pharmacological reports : PR.

[16]  P. Vardas,et al.  Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[17]  P. McCarthy,et al.  PET abnormalities in patients with nonischemic cardiomyopathy. , 2004, Journal of cardiac failure.

[18]  K. Airaksinen,et al.  Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy. , 2004, Journal of cardiac failure.

[19]  J. Hatazawa,et al.  Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers. , 2004, Journal of the American College of Cardiology.

[20]  K. Ito,et al.  Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy , 2003, Nuclear medicine communications.

[21]  Diwakar Jain,et al.  Direct Imaging of Exercise-Induced Myocardial Ischemia With Fluorine-18–Labeled Deoxyglucose and Tc-99m-Sestamibi in Coronary Artery Disease , 2003, Circulation.

[22]  P. Iozzo,et al.  Myocardial metabolic and receptor imaging in idiopathic dilated cardiomyopathy , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  P. Herrero,et al.  Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[24]  Gianmario Sambuceti,et al.  Myocardial perfusion and coronary microcirculation: From pathophysiology to clinical application , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[25]  D. Neglia,et al.  Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.

[26]  P Stanko,et al.  An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  X. Liu,et al.  Radionuclide techniques for evaluating dilated cardiomyopathy and ischemic cardiomyopathy. , 2000, Chinese medical journal.

[28]  H. Crijns,et al.  Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[29]  N. Danchin,et al.  Radionuclide assessment of regional differences in left ventricular wall motion and myocardial perfusion in idiopathic dilated cardiomyopathy. , 1993, European heart journal.

[30]  R. Testa,et al.  Myocardial Blood Flow Distribution in Patients With Ischemic Heart Disease or Dilated Cardiomyopathy Undergoing Heart Transplantation , 1993, Circulation.

[31]  Y. Doi,et al.  Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. , 1992, The American journal of cardiology.

[32]  K. Tsuiki,et al.  Segmental wall motion abnormalities in dilated cardiomyopathy: hemodynamic characteristics and comparison with thallium-201 myocardial scintigraphy. , 1987, American heart journal.

[33]  W. Roberts,et al.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[34]  R. Magorien,et al.  The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. , 1983, American heart journal.